Stockholders' Equity

12 Months Ended

Dec. 31, 2022

Stockholders' Equity Attributable to Parent [Abstract]

Stockholders' Equity

Zoetis is authorized to issue 6 billion shares of common stock and 1 billion shares of preferred stock.

In December 2018, our Board of Directors authorized a $2.0 billion share repurchase program. This program was completed as of June 30, 2022. In December 2021, our Board of Directors authorized an additional $3.5 billion share repurchase program. As of December 31, 2022, there was $2.6 billion remaining under this authorization. Purchases of Zoetis shares may be made at the discretion of management, depending on market conditions and business needs.

Accumulated other comprehensive loss

Changes, net of tax, in accumulated other comprehensive loss, excluding noncontrolling interest, follow:

			Currency Translation Adjustments				Benefit Plans		Accumulated Other
	Cash Flow		Net Investment		Other Currency		Actuarial		Comprehensive
(MILLIONS OF DOLLARS)	Hedges		Hedges		Translation Adj		(Losses)/Gains		Loss
Balance, December 31, 2019	$	—	$	21	$	(724)	$	(23)	$	(726)
Other comprehensive (loss)/gain, net of tax	(15)		(58)		69		—		(4)
Balance, December 31, 2020	(15)		(37)		(655)		(23)		(730)
Other comprehensive gain/(loss), net of tax	19		42		(101)		6		(34)
Balance, December 31, 2021	4		5		(756)		(17)		(764)
Other comprehensive gain/(loss), net of tax	86		36		(188)		13		(53)
Balance, December 31, 2022	$	90	$	41	$	(944)	$	(4)	$	(817)